Aranesp Related To Four Cases Of PRCA, Far Below Eprex Rate, Amgen Says
Executive Summary
Amgen is reporting four cases of pure red cell aplasia in Aranesp (darbepoetin alfa) patients
You may also be interested in...
EPO Warning Enhancement Reflects Expanded FDA Adverse Event Definition
Strengthened warnings for antibody-mediated anemia in labeling for erythropoietin products reflect an expanded definition of the adverse events, FDA said Dec. 2
EPO Warning Enhancement Reflects Expanded FDA Adverse Event Definition
Strengthened warnings for antibody-mediated anemia in labeling for erythropoietin products reflect an expanded definition of the adverse events, FDA said Dec. 2
Amgen Epogen To Add Aplasia Warning, Brought In Line With J&J’s Procrit
Amgen Epogen (epoetin alfa) will add a warning for pure red cell aplasia to its labeling after consulting with FDA